By IANS,
New Delhi : India’s largest drug manufacture Ranbaxy Laboratories announced Tuesday a net profit of Rs.1.6 billion ($39 million) on a consolidated basis in the second quarter of this year ending June 30, exactly the same gain made in the comparable period last year. The firm starts its accounting year Jan 1.
Total sales at Rs.18.3 billion ($440 million) in the quarter under review was up 13 percent from Rs.16.2 billion ($395 millon) earned in the previous quarter.